Latest News

German palliative doctor charged with 15 counts of murder

Prosecutors in Berlin on Wednesday charged a doctor suspected of administering lethal amounts of various medications to palliative patients under his care with 15 counts of murder.

Prosecutors are also seeking a lifelong professional ban for the 40-year-old suspect, detained since August 2024, who had been active in several German states.

The suspect, not officially named in line with German privacy laws, has not admitted the charges, said prosecutors.

He was initially suspected of being involved in four deaths last year, which prosecutors said he had tried to cover up by setting fire to the victims’ apartments. However, ongoing investigations have turned up more suspected deaths, dating back to 2021, and that number could rise even further.

An investigative team set up specifically for the case is evaluating his patient records and more exhumations are planned.

The doctor is accused of administering an anaesthetic and then a muscle relaxant to palliative patients under his care who were not actively dying and without their knowledge or consent, said prosecutors.

This post appeared first on cnn.com

You May Also Like

Stock

Exploring Market Predictions for Shiba Inu Shiba Inu, also known by its cryptocurrency market name as SHIB, is reportedly setting the stage for a...

Stock

As global interest in cryptocurrency playback grows, the Ripple coin XRP has become a hot topic of conversation, especially with the latest news suggesting...

Investing

In the realm of the mineral sector, the recent years have witnessed several remarkable shifts. The waves of change have brought a deep focus...

Editor's Pick

ESPN – The Worldwide Leader in Sports, has been making major strides to expand its reach and digestibility to a more general audience by...

Disclaimer: Finlosofi.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 Finlosofi.com